Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a Canada-based practitioner-focused digital healthcare company. Its healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services. Its solutions enable more than 38,000 healthcare providers between the United States and Canada and power owned and operated healthcare ecosystem in Canada with over 200 clinics supporting primary care, specialized care, and diagnostic services. In the United States its solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL Health USA Patient and Provider Services consists of four assets: CRH Medical, Provider Staffing, Circle Medical and Wisp. It provides cybersecurity protection and patient data privacy solutions.


TSX:WELL - Post by User

Post by speedy99on May 16, 2021 9:31am
388 Views
Post# 33211087

sales growth

sales growthMany analysts were still basing valuations on last year's sales of $50.24 mill.  Some were looking out to 2021 and thinking $100 mill might be possible.  Before CRH acquistion our CEO was saying we would easily reach $100 mill.  That has been confirmed by the recently reported first quarter numbers, which is extrapolated over the year take us over $100 mill.  Hardly any are doing the analysis based on 2021 projection of $300 mill in sales.  Its easier to take a conservative approach and base a share price calculation on the known sales and see only $100 mill for this year.  But CRH was truly a game changer and we are looking at $300 mill in sales, not $100.00 mill.  This year truly is the beginning of WELL 2.0.    For reference to sales, see below.

2018      -       $5.90 million in sales

2019      -     $32.80 miillion in sales

2020     -      $50.24 million in sales

2021     -    $300.00 million in sales
<< Previous
Bullboard Posts
Next >>